Andy Kim - Samsung Biologics Exec center
| 207940 Stock | 980,000 6,000 0.62% |
Executive
Andy Kim is Exec center of Samsung Biologics Co
| Age | 59 |
| Phone | (82) 33 455 3825 |
| Web | www.samsungbiologics.com |
Samsung Biologics Management Efficiency
The company has return on total asset (ROA) of 0.0422 % which means that it generated a profit of $0.0422 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0751 %, meaning that it generated $0.0751 on every $100 dollars invested by stockholders. Samsung Biologics' management efficiency ratios could be used to measure how well Samsung Biologics manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | EXECUTIVE Age | ||
| Yeolgi Sung | Shinsegae Food | 61 | |
| Son SunJong | Cloud Air CoLtd | 64 | |
| Su Jeon | Sangsin Energy Display | 61 | |
Management Performance
| Return On Equity | 0.0751 | |||
| Return On Asset | 0.0422 |
Samsung Biologics Leadership Team
Elected by the shareholders, the Samsung Biologics' board of directors comprises two types of representatives: Samsung Biologics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Samsung. The board's role is to monitor Samsung Biologics' management team and ensure that shareholders' interests are well served. Samsung Biologics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Samsung Biologics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Hoyeol Yoon, Ex VP | ||
| John Rim, Pres CEO | ||
| James Park, MD VP | ||
| Doyoung Heo, VP Relations | ||
| James Choi, Chief VP | ||
| Hyung Moon, Head VP | ||
| Andy Kim, Exec center | ||
| DongJoong Kim, Ex CFO | ||
| Yong Park, CHRO VP | ||
| TaeHan Kim, Ex Chairman |
Samsung Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Samsung Biologics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0751 | |||
| Return On Asset | 0.0422 | |||
| Profit Margin | 0.20 % | |||
| Operating Margin | 0.32 % | |||
| Current Valuation | 58.92 T | |||
| Shares Outstanding | 71.17 M | |||
| Shares Owned By Insiders | 75.18 % | |||
| Shares Owned By Institutions | 13.80 % | |||
| Price To Book | 6.92 X | |||
| Price To Sales | 23.45 X |
Pair Trading with Samsung Biologics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Samsung Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Samsung Biologics will appreciate offsetting losses from the drop in the long position's value.Moving together with Samsung Stock
| 0.66 | 302440 | SK Bioscience | PairCorr |
| 0.74 | 326030 | Sk Biopharmaceuticals | PairCorr |
| 0.61 | 298380 | ABL Bio | PairCorr |
| 0.76 | 144510 | Green Cross Lab | PairCorr |
Moving against Samsung Stock
The ability to find closely correlated positions to Samsung Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Samsung Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Samsung Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Samsung Biologics Co to buy it.
The correlation of Samsung Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Samsung Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Samsung Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Samsung Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Samsung Stock
Samsung Biologics financial ratios help investors to determine whether Samsung Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Samsung with respect to the benefits of owning Samsung Biologics security.